Eiger BioPharmaceuticals, Inc. — Form D

Eiger BioPharmaceuticals, Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2011-09-01. The offering totals $250K, of which $250K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
Rebecque LabaExecutive OfficerSan Diego, CA
Krisztina ZseboDirectorSan Diego, CA
Krisztina ZseboExecutive OfficerSan Diego, CA
Asish XavierDirectorSouth San Francisco, CA
Jeffrey S GlennDirectorPalo Alto, CA
Asish R XavierDirectorSan Diego, CA
Graham E CooperDirectorBrisbane, CA
Nina S KjellsonDirectorPalo Alto, CA
Joanne H QuanExecutive OfficerPalo Alto, CA
Charles J BramlageDirectorPalo Alto, CA
Thomas J DietzDirectorPalo Alto, CA
James H WelchExecutive OfficerPalo Alto, CA
James P ShafferExecutive OfficerPalo Alto, CA
David A CoryDirectorPalo Alto, CA
David A CoryExecutive OfficerPalo Alto, CA
Eduardo Bruno MartinsExecutive OfficerPalo Alto, CA
Edgar G EnglemanDirectorPleasanton, CA
Gregg E AltonDirectorSan Diego, CA
Joshua E FunderDirectorSan Diego, CA
Michael E NarachiDirectorSan Diego, CA
Todd E FoleyDirectorSan Diego, CA
Fouad E AzzamDirectorSan Diego, CA
Daniel E OmsteadDirectorSan Diego, CA
Andrew E SenyeiDirectorSan Diego, CA
Lauren E SilvermanDirectorSan Diego, CA

Other filings by this issuer (11)

FiledFormOfferingSold
2016-04-29D$3.0M$3.0M
2013-10-25D$2.4M$1.1M
2012-05-08D/A$64.5M$19.5M
2012-02-06D$61.3M$17.8M
2011-12-22D$500K$500K
2011-11-16D$500K$330K
2011-10-28D$200K$200K
2011-07-12D$400K$400K
2010-10-28D$4.0M$2.5M
2009-12-17D$6.5M$3.5M
2009-09-10D/A$24.6M$21.8M

More